We are pleased to share an important milestone for Expecto Health Science: achievement of First Patient In (FPI) in a global clinical study within five months of regulatory submission.
This achievement reflects Expectoβs vision to make new therapies accessible to patients through efficient, high-quality clinical trials. It demonstrates what can be accomplished through clarity, accountability, and seamless cross-functional collaboration.
